Diagnosis of esophageal ulcers in acquired immunodeficiency syndrome.

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Diagnosis of esophageal ulcers in acquired immunodeficiency syndrome.

Semin Gastrointest Dis. 1999 Jul;10(3):85-92. Unique Identifier : AIDSLINE MED/99362048
Monkemuller KE; Wilcox CM; Department of Medicine, University of Alabama at Birmingham,; 35294-0007, USA.

Abstract: The esophagus is one of the most common sites of gastrointestinal involvement in human immunodeficiency virus (HIV)-infected patients, with at least 30% of the patients having esophageal symptoms at some point during the course of HIV infection. Esophageal ulcers are commonly caused by infections such as cytomegalovirus (CMV) or may be idiopathic. The clinical presentation of the various causes of esophageal ulcers are similar; therefore, a thorough endoscopic and histological workup is imperative to make a diagnosis and, consequently, to provide appropriate therapy. The widespread use of more effective antiretroviral therapy appears to have led to a decline in gastrointestinal opportunistic disorders in patients with acquired immunodeficiency syndrome (AIDS), including those involving the esophagus. Unfortunately, there are several reports of resistance of HIV-1 to multiple antiretroviral agents, and thus it is possible we will observe an increase in various opportunistic disorders again. The aim of this article is to provide a practical approach to the clinical, endoscopic, and histopathologic evaluation of esophageal ulcers in patients with AIDS.

Keywords: JOURNAL ARTICLE Adult AIDS-Related Opportunistic Infections/*DIAGNOSIS/DRUG THERAPY Candidiasis/DRUG THERAPY/MICROBIOLOGY Case Report Cytomegalovirus Infections/DRUG THERAPY/MICROBIOLOGY Esophageal Diseases/*DIAGNOSIS/DRUG THERAPY/MICROBIOLOGY Esophagitis/DRUG THERAPY/MICROBIOLOGY Herpes Simplex/DRUG THERAPY/MICROBIOLOGY Human HIV-1 Male Middle Age Ulcer/*DIAGNOSIS/DRUG THERAPY/MICROBIOLOGY
991230
A99C1020

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .